Eton Pharmaceuticals Inc — Balance Sheet (NASDAQ:ETON) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Total assets 26.32 M27.46 M25.03 M31.74 M76.12 M Total liabilities 10.66 M9.84 M11.95 M16.26 M51.7 M Total equity 15.66 M17.63 M13.08 M15.48 M24.43 M Total liabilities & shareholders' equities 26.32 M27.46 M25.03 M31.74 M76.12 M Total debt ————— Net debt —————

Nouvelles

La solution orale DESMODA reçoit l’approbation de la FDA pour le diabète insipide

DESMODA oral solution receives FDA approval for diabetes insipidus

Le titre d’Eton Pharmaceuticals grimpe après l’acquisition d’une licence pour un médicament contre une maladie ultra-rare

Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug

Eton Pharmaceuticals licenses ultra-rare disease treatment candidate

Implied Volatility Surging for Eton Pharmaceuticals Stock Options

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Le BPA de Eton Pharmaceuticals a manqué les attentes de 0,07$, le CA a surpassé les prévisions

Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday

Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold

Monopar Therapeutics: A Healthy Dose Of Skepticism Warranted (NASDAQ:MNPR)